Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06106958 · ClinicalTrials.gov registry record · NA

Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy

A NA study of Plantar Fascitis and Plantar Fasciitis of Both Feet, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT06106958: Completed NA study of Plantar Fascitis and Plantar Fasciitis of Both Feet, sponsored by University of Virginia.

NCT06106958 is a NA study of Plantar Fascitis and Plantar Fasciitis of Both Feet that has completed, run by University of Virginia. The registered enrollment target is 37 participants, below the 90-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06106958, a NA study of Plantar Fascitis and Plantar Fasciitis of Both Feet, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to compare the effects of 8 weeks of foot rehabilitation exercises in conjunction with wearing minimalist shoes in individuals with plantar fasciopathy, compared to only performing foot rehabilitation exercises. The main questions it aims to answer are: * Will individuals with plantar fasciopathy be able to reduce their pain and improve their self-reported function by performing rehabilitation exercises and wearing minimalist shoes, compared to those only performing rehabilitation exercises? * Will individuals with plantar fasciopathy be able to increase their intrinsic foot muscle strength and size, their balance, and gait biomechanics by performing rehabilitation exercises and wearing minimalist shoes, compared to those only performing rehabilitation exercises? * What characteristics of individuals with plantar fasciopathy make them most suited to succeed in a protocol of performing rehabilitation exercises and wearing minimalist shoes? Participants will be asked to come into the lab at the start of the intervention and after 8 weeks, where the following will be assessed: * Patient-reported outcomes * Foot morphology * Intrinsic foot muscle strength * Balance * Gait biomechanics For the intervention, participants in both groups will perform the same rehabilitation exercises, including: * Massage to the bottom of the foot * Calf-raises * Calf and foot stretches

Primary Outcome

Visual Analog Scale (0-100 mm) pain outcome scores for the following items: * Average pain over the past week * First-step pain over the past week (the pain that is felt upon waking up in the morning and taking a first step) * Average heel pain of the day

Interventions

  • BEHAVIORAL Home Exercise Program
  • BEHAVIORAL Minimalist Shoes

Study Locations (1)

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2024-02-14
Est. Completion 2025-01-20
Phase NA
University of Virginia

449 total trials

What the finished NCT06106958 record still lists

NCT06106958 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 90-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (59% lower).

The record links to 6 conditions, with Plantar Fascitis appearing as the primary indexed condition, and to 2 interventions - of which Home Exercise Program is the first listed.

NCT06106958 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT06106958 about?

NCT06106958 is a clinical study titled "Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy". The goal of this clinical trial is to compare the effects of 8 weeks of foot rehabilitation exercises in conjunction with wearing minimalist shoes in individuals with plantar fasciopathy, compared to only performing foot rehabilitation exercises. The main questions it aims to answer are: * Will ind...

What is the current status of trial NCT06106958?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2024-02-14. Estimated completion is 2025-01-20.

What conditions does trial NCT06106958 study?

This clinical trial studies the following conditions: Plantar Fascitis, Plantar Fasciitis of Both Feet, Plantar Fasciitis, Chronic, Plantar Fasciopathy, Plantar Fasciitis of Right Foot.

What interventions are being tested in trial NCT06106958?

The interventions under investigation include: Home Exercise Program (BEHAVIORAL), Minimalist Shoes (BEHAVIORAL).

Who is sponsoring clinical trial NCT06106958?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06106958 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Plantar Fascitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02800486 · 37 participants · Phase 2

    Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • NCT03173937 · 37 participants · Phase 1

    Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

  • NCT03295227 · 37 participants · Phase 1

    Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

  • NCT03401047 · 37 participants · Early Phase 1

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06106958, the US trial registry maintained by the National Library of Medicine. NCT06106958 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.